Skip to content
DRS

Leonardo DRS, Inc.

Leonardo DRS, Inc. Q4 FY2025 earnings call

February 24, 2026 · fiscal period ended 2025-12

EPS · actual vs est

$0.42 / $0.37Beat +13.5%

Revenue · actual vs est

$1.06B / $833.5MBeat +27.2%
Ask about this call

Summary

Generated 2026-02-24

Management highlights

• John Baylouny thanked Bill Lynn and discussed his priorities as CEO: build on success, accelerate operating cadence, empower people. • Macro environment: dynamic with global threats, defense spending increasing, company's book-to-bill ratio 1.2 or better for 4th consecutive year. • 2025 investment: R&D up 40%, CapEx up over 60%, 2026 CapEx expected to trend to ~5% of revenue, ramping operations in Charleston, investing in various product areas. • Fourth quarter highlights: space market win, infrared sensing growth, tactical radars demand, Columbia Class program execution, Sally Wallace's new role as COO.

View in transcript ↓

Segment performance

Advanced Sensing and Computing segment: Q4 revenue growth 9%, full year 11%. Integrated Mission Systems segment: Q4 year-over-year growth 5%, full year 15% driven by electric power and propulsion and counter UAS programs. Full year 2025 had record bookings, 13% organic revenue growth, year-end backlog $8.7 billion, adjusted EBITDA growth tracked with revenue, margins flat due to increased R&D, supply chain issues, and unusual items.

View in transcript ↓

Guidance

• Revenue range 2026: $3.85 billion to $3.95 billion, 6%-8% organic growth. • Adjusted EBITDA range 2026: $505 million to $525 million, margin improvement 70-90 basis points. • Adjusted diluted EPS range 2026: $1.20 to $1.26 per share. • Q1 2026 revenue low 800s, adjusted EBITDA margin low 11% range, second half of year contributes more than half of revenue and adjusted EBITDA.

View in transcript ↓

Q&A highlights

Q: Robert Stallard asked about potential upside from reconciliation bill and book-to-bill suggesting revenue growth.

A: John Baylouny said some alignment with priority areas but early days; John Baylouny said optimistic on growth but diverse portfolio has elongated conversion cycle.

Q: Michael Ciarmoli asked about ground revenue program winding down and cap structure.

A: Michael Dippold said portfolio has elements growing at different rates; John Baylouny said top priority organic investments first then inorganic.

Q: Seth Seifman asked about IMS profitability and Charleston capacity.

A: Michael Dippold said margin from volume leverage and Columbia being tailwind; John Baylouny said Charleston capacity for modular electric architecture applicable to different ship sizes.

Q: Austin Moeller asked about Tranche 3 award and Charleston capacity for new ships.

A: John Baylouny said can't comment on award size, focused on execution; John Baylouny said Navy likely to buy different size ships and Charleston capacity applicable.

Q: Jonathan Tanwanteng asked about quantum laser license and CapEx.

A: John Baylouny said quantum cascade laser technology used, look for noncore licensing opportunities; Michael Dippold said CapEx for capacity in naval and tactical radars areas.

Q: Andre Madrid asked about EBITDA margin and book-to-bill softening.

A: Michael Dippold said business structured for mid-teens margins, John Baylouny said focus on portfolio to increase growth speed.

Q: Ronald Epstein asked about Europe opportunities and laser IP licensing.

A: John Baylouny said collaboration with Leonardo for European and US markets, laser IP licensed out to focus on defense; Michael Dippold said laser IP has nondefense utility but focus on defense.

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS$0.42$0.37+13.5%$0.38
Revenue$1.06B$833.5M+27.2%$981.0M

Transcript

February 24, 2026

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.